Atlas FDA

HANCOCK MODIFIED ORIFICE VALVED CONDUIT MODEL 150

FDA premarket approval P790007/S032 · decided 2013-01-10

Approval details

PMA number
P790007
Supplement
S032
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
HANCOCK MODIFIED ORIFICE VALVED CONDUIT MODEL 150
Generic name
heart-valve, non-allograft tissue
Applicant
Medtronic Heart Valves
Date received
2012-03-23
Decision date
2013-01-10
Days to decision
293 days
Decision code
APPR
Product code
LWR
Advisory committee
Cardiovascular
Expedited review
No
Location
Santa Ana, CA
Statement
APPROVAL FOR THE GLUTARALDEHYDE STOCK SOLUTION THAT IS OBTAINED FROM DOWCHEMICAL FOR THE FIXATIVE, STORAGE, AND STERILIZATION SOLUTIONS TO BE CHANGED FROM A 25% STOCK SOLUTION TO A 50% STOCK SOLUTION.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SIMPLICI-T ANNULOPLASTY SYSTEM (K052970)Medtronic Heart Valves2006-01-11
CG FUTURE ANNULOPLASTY BAND (K052860)Medtronic Heart Valves2005-11-10
DURAN BAND (MODEL H607H), DURAN RING (MODEL 610R), DURAN BAND (MODEL 610B), DURAN ANCORE RING (MODEL 620R), DURAN ANCORE (K032810)Medtronic Heart Valves2003-12-05